Muscle weakness after administration of neuromuscular blocking agents: do not immobilize the diaphragm unnecessarily.
Eikermann
Matthias
M
Chamberlin
Nancy L
NL
Gerber
Helmut
H
Malhotra
Atul
A
D000732:Androstanols / Q000009:adverse effects*; D000818:Animals; D003964:Diaphragm / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D009133:Muscular Atrophy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D051381:Rats; D012121:Respiration, Artificial / Q000009:adverse effects*; D000077123:Rocuronium
D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D000077123:Rocuronium